TrialJournal of Crohn's & colitis2023

Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments.

Maria M E Jongsma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.